Canada markets closed

NeutriSci International Inc. (NU.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.06500.0000 (0.00%)
At close: 01:35PM EST
Full screen
Previous Close0.0650
Open0.0650
Bid0.0650 x 0
Ask0.0700 x 0
Day's Range0.0650 - 0.0650
52 Week Range0.0500 - 0.3500
Volume2,000
Avg. Volume111,713
Market Cap10.798M
Beta (5Y Monthly)2.08
PE Ratio (TTM)N/A
EPS (TTM)-0.0110
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    NEUTRISCI SIGNS EXCLUSIVE 5-YEAR DISTRIBUTION AGREEMENT FOR EUROPE AND RECEIVES INITIAL ORDER

    NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), an innovative technology company developing products for the nutraceutical industry, is very pleased to announce that it has executed a definitive agreement (the "Agreement") with TH International Consulting GmbH ("THIC") for the distribution of neuenergy™ in Europe. Founded in 2012 and based in Esslingen, Germany, THIC is successfully active in the areas of consulting, marketing, as well as

  • CNW Group

    NEUTRISCI UPDATES MANAGEMENT DISCUSSION AND ANALYSIS'

    NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU) (OTCQB: NRXCF) (FSE: 1N9), announces that as a result of a review by the British Columbia Securities Commission it has refiled its management discussion & analysis for the six- and nine-month periods ended June 30, 2021 and September 30, 2021 (collectively, the "MD&A"). The refiled MD&A includes additional disclosure regarding a one-time financial loss incurred by the Company, and which was already reflected in the accompany

  • ACCESSWIRE

    NeutriSci Announces Successful Completion of R&D in Preparation for Launch of Its Functional Mushroom Product Line

    VANCOUVER, BC / ACCESSWIRE / November 30, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company")(TSXV:NU)(OTCQB:NRXCF)(FSE:1N9), an innovative technology company developing products for the nutraceutical industry, is pleased to announce that is has successfully completed the R&D of a newly developed effervescent functional mushroom tablet product for online sales in Europe and North America.